Effects of Rho-kinase and Src protein tyrosine kinase inhibition on agonist-induced vasoconstriction of arteries and veins of the equine laminar dermis

American Journal of Veterinary Research

Volumn 68, Issue 8, 2007, Pages 886-894

  Robertson, Tom P ^a   Moore, James N ^a   Noschka, Erik ^a   Lewis, Tristan H ^a   Lewis, Stephen J ^a   Peroni, John F ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ENDOTHELIN 1; PHENYLEPHRINE; PROSTAGLANDIN F2 ALPHA; PROTEIN TYROSINE KINASE; RHO KINASE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HOOF AND CLAW; HORSE; LAMINA PROPRIA; LIMB BLOOD VESSEL; NONHUMAN; PROTEIN FUNCTION; SHIFT TO THE RIGHT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

AMIDES; ANIMALS; ARTERIES; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FOOT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHENYLEPHRINE; PROTEIN-SERINE-THREONINE KINASES; PYRAZOLES; PYRIDINES; PYRIMIDINES; SEROTONIN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VEINS;

EQUIDAE;

EID: 34548268685     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.8.886     Document Type: Article

References (35)

1. Sloet van Oldruitenborgh-Oosterbaan MM. Laminitis in the horse: a review. Vet Q 1999;21:121-127.
2. Adair HS III, Goble DO, Schimidhammer JL, et al. Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses. Am J Vet Res 2000;61:862-868.
3. Galey FD, Twardock AR, Goetz TE, et al. Gamma scintigraphic analysis of the distribution of perfusion of blood in the equine foot during black walnut (Juglans nigra)-induced taminitis. Am J Vet Res 1990;51:688-695.
4. Allen D Jr, Clark ES, Moore JN, et al. Evaluation of equine digital Starling forces and hemodynamics during early laminitis. Am J Vet Res 1990;51:1930-1934.
5. Eaton SA, Allen D, Eades SC, et al. Digital Starling forces and hemodynamics during early laminitis induced by an aqueous extract of black walnut (Juglans nigra) in horses. Am J Vet Res 1995;56:1338-1344.
6. Hurley DJ, Parks RJ, Reber AJ, et al. Dynamic changes in circulating leukocytes during the induction of equine laminitis with black walnut extract. Vet Immunol Immunopathol 2006;110:195-206.
7. Eades SC, Stokes AM, Moore RM. Effects of an endothelin receptor antagonist and nitroglycerin on digital vascular function in horses during the prodromal stages of carbohydrate overload-induced laminitis. Am J Vet Res 2006;67:1204-1211.
8. Waguespack RW, Cochran A, Belknap JK. Expression of the cyclooxygenase isoforms in the prodromal stage of black walnut-induced laminitis in horses. Am J Vet Res 2004;65:1724-1729.
9. Robertson TP, Peroni JE Lewis SJ, et al. Effects of induction of capacitative calcium entry on equine laminar microvessels. Am J Vet Res 2005;66:1877-1880.
10. Peroni JF, Harrison WE, Moore JN, et al. Black walnut extract-induced laminitis in horses is associated with heterogeneous dysfunction of the laminar microvasculature. Equine Vet J 2005;37:546-551.
11. Peroni JF, Moore JN, Noschka E, et al. Predisposition for venoconstriction in the equine laminar dermis: implications in equine laminitis. J Appl Physiol 2006;100:759-763.
12. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and nonmuscle myosin II. J Physiol 2000;522:177-185.
13. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994;372:231-236.
14. DeFeo TT, Morgan KG. Calcium-force relationships as detected with aequorin in two different vascular smooth muscles of the ferret. J Physiol 1985;369:269-282.
15. Morgan JP, Morgan KG. Stimulus-specific patterns of intracellular calcium levels in smooth muscle of ferret portal vein. J Physiol 1984;351:155-167.
16. Nishimura J, Khalil RA, van Breemen C. Agonist-induced vascular tone. Hypertension 1989;13:835-844.
17. 2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation. Arch Biochem Biophys 1995;320:236-242.
18. Nagao M, Kaziro Y, Itoh H. The Src family tyrosine kinase is involved in Rho-dependent activation of c-Jun N-terminal kinase by Galpha12. Oncogene 1999;18:4425-4434.
19. 2+ sensitization of coronary artery contraction mediated by a sphingosylphosphorylcholine-Rho-kinase pathway Circ Res 2002;91:953-960.
20. 2+ sensitization of smooth muscle of rabbit mesenteric artery. Br J Pharmacol 1998;125:1651-1660.
21. 2000 Report of the AVMA Panel on Euthanasia. J Am Vet Med Assoc 2001;218:669-696.
22. Winer BJ. Analysis of variance. In: Statistics principles in experimental design. New York: McGraw-Hill, 1971;752-809.
23. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
24. Hanke JH, Gardner JP, Dow RL, et al. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem 1996;271:695-701.
25. Hood DM. The pathophysiology of developmental and acute laminitis. Vet Clin North Am Equine Pract 1999;15:321-343.
26. Hood DM, Grosenbaugh DA, Mostafa MB, et al. The role of vascular mechanisms in the development of acute equine laminitis. J Vet Intern Med 1993;7:228-234.
27. Moore RM, Eades SC, Stokes AM. Evidence for vascular and enzymatic events in the pathophysiology of acute laminitis: which pathway is responsible for initiation of this process in horses? Equine Vet J 2004;36:204-209.
28. Tamura M, Nakao H, Yoshizaki H, et al. Development of specific Rho-kinase inhibitors and their clinical application. Biochim Biophys Acta 2005;1754:245-252.
29. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005;25:1767-1775.
30. Lee MW, Severson DL. Signal transduction in vascular smooth muscle: diacylglycerol second messengers and PKC action. Am J Physiol 1994;267:C659-C678.
31. Di Salvo J, Pfitzer G, Semenchuk LA. Protein tyrosine phosphorylation, cellular Ca2+, and Ca2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 1994;72:1434-1439.
32. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990-994.
33. Davies SP, Reddy H, Caivano M, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
34. Robertson TP, Michelakis ED, Rochefort GY. Release of an endothelium-derived vasoconstrictor and RhoA/Rho kinase mediated calcium sensitization of smooth muscle cell contraction are/are not the main effectors for full and sustained hypoxic pulmonary vasoconstriction. J Appl Physiol 2007;102:2071-2072.
35. Evans AM, Cobban HJ, Nixon GF. ET(A) receptors are the primary mediators of myofilament calcium sensitization induced by ET-1 in rat pulmonary artery smooth muscle: a tyrosine kinase independent pathway. Br J Pharmacol 1999;127:153-160.